These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15485171)

  • 21. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria.
    Sanada S; Tanaka T; Kameyoshi Y; Hide M
    Arch Dermatol Res; 2005 Sep; 297(3):134-8. PubMed ID: 16044256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of otitis media with effusion after treatment of asthma with leukotriene antagonists in children with co-existing disease.
    Balatsouras DG; Eliopoulos P; Rallis E; Sterpi P; Korres S; Ferekidis E
    Drugs Exp Clin Res; 2005; 31 Suppl():7-10. PubMed ID: 16444906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nivolumab-induced systemic capillary leak syndrome as an ultra rare life-threatening phenomenon of late toxicity and intravenous immunoglobulin efficacy.
    Polishchuk I; Yakobson A; Zemel M; A Sharb A; Shalata W; Rosenberg E; A Kian T; Alguayn F; Peled N; Rouvinov K; Alguayn W; Kian W
    Immunotherapy; 2021 Jul; 13(10):807-811. PubMed ID: 33969699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of leukotriene receptor antagonists for dysmenorrhea of endometriosis.
    Konno R; Fujiwara H; Suzuki M
    Fam Med; 2004 Jan; 36(1):8-9. PubMed ID: 14710319
    [No Abstract]   [Full Text] [Related]  

  • 25. Capillary leakage syndrome: a case report and a review.
    Garcês S; Araújo F; Rego F; Soares JL; Carlos AG
    Allerg Immunol (Paris); 2002 Dec; 34(10):361-4. PubMed ID: 12575619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic systemic capillary leak syndrome treatment with intravenous immune globulin: Case report and review of the literature
.
    Mullane R; Langewisch E; Florescu M; Plumb T
    Clin Nephrol; 2019 Jan; 91(1):59-63. PubMed ID: 30431430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose intravenous immunoglobulins: a promising therapeutic approach for idiopathic systemic capillary leak syndrome.
    Zipponi M; Eugster R; Birrenbach T
    BMJ Case Rep; 2011 May; 2011():. PubMed ID: 22696704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic capillary leak syndrome presenting as recurrent shock.
    Karatzios C; Gauvin F; Egerszegi EP; Tapiero B; Buteau C; Rivard GE; Ovetchkine P
    Pediatr Crit Care Med; 2006 Jul; 7(4):377-9. PubMed ID: 16738498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two cases of systemic capillary leak syndrome that were treated with pentastarch.
    Lee YS; Kim SY; Kwon CW; Song HG; Lee YK; Kim HJ; Zang DY
    Korean J Intern Med; 2007 Jun; 22(2):130-2. PubMed ID: 17616032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Episodic idiopathic systemic capillary leak syndrome in a girl.
    Milani GP; Dellepiane RM; Castellazzi ML; Mazzoni MB; Bianchetti MG; Fossali EF
    Pediatr Int; 2013 Aug; 55(4):e81-2. PubMed ID: 23910812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA).
    Lee SY; Kim HB; Kim JH; Kim BS; Kang MJ; Jang SO; Seo HJ; Hong SJ
    Clin Exp Allergy; 2007 Oct; 37(10):1487-93. PubMed ID: 17883728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Montelukast for treatment of refractory pruritus in patients on hemodialysis.
    Nasrollahi AR; Miladipour A; Ghanei E; Yavari P; Haghverdi F
    Iran J Kidney Dis; 2007 Oct; 1(2):73-7. PubMed ID: 19363280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukotriene receptor antagonists: a good choice in the treatment of premenstrual asthma?
    Pasaoglu G; Mungan D; Abadoglu O; Misirligil Z
    J Asthma; 2008 Mar; 45(2):95-9. PubMed ID: 18350399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idiopathic systemic capillary leak syndrome (Clarkson disease).
    Druey KM; Parikh SM
    J Allergy Clin Immunol; 2017 Sep; 140(3):663-670. PubMed ID: 28012935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Montelukast is not effective in controlling allergic symptoms outside the airways: a randomised double-blind placebo-controlled crossover study.
    Lehtimäki L; Petäys T; Haahtela T
    Int Arch Allergy Immunol; 2009; 149(2):150-3. PubMed ID: 19127072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic systemic capillary leak syndrome: novel therapy for acute attacks.
    Dowden AM; Rullo OJ; Aziz N; Fasano MB; Chatila T; Ballas ZK
    J Allergy Clin Immunol; 2009 Nov; 124(5):1111-3. PubMed ID: 19703708
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral monteleukast in urticaria induced by nonsteroidal anti-inflammatory drugs.
    Goel A; Prasad D
    J Eur Acad Dermatol Venereol; 2007 Oct; 21(9):1275-6. PubMed ID: 17894732
    [No Abstract]   [Full Text] [Related]  

  • 38. Idiopathic systemic capillary leak syndrome in children.
    Hsu P; Xie Z; Frith K; Wong M; Kakakios A; Stone KD; Druey KM
    Pediatrics; 2015 Mar; 135(3):e730-5. PubMed ID: 25713284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Montelukast in guidelines and beyond.
    Bousquet J; Demoly P; Humbert M
    Adv Ther; 2009 Jun; 26(6):575-87. PubMed ID: 19562275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Value of leukotriene antagonists in bronchial asthma].
    Petro W; Bachert C
    Krankenpfl J; 2004; 42(7-10):257. PubMed ID: 15675415
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.